Loading organizations...

§ Venture Capital · Beijing, China
Zhongjin Qichen Industry Equity Investment Fund constructs a diversified private equity investment portfolio, primarily focusing on growth-stage companies within key strategic sectors. Operating under the management of CICC Capital, the fund directs capital into healthcare, technology, advanced manufacturing, and consumer industries. Its core capability lies in identifying and nurturing enterprises poised for significant development, contributing to China's industrial upgrading and technological advancement through judicious capital allocation.
The fund's operational framework stems from CICC Capital, the dedicated private equity platform of China International Capital Corporation (CICC), which was founded in 1995. CICC Capital established its first private equity entity in 2007, recognizing the imperative to leverage private capital for economic transformation. This foundational insight positions Zhongjin Qichen to channel investment into areas vital for national development, benefiting from CICC's extensive financial expertise and market acumen.
Zhongjin Qichen serves its limited partners, including institutional investors and government investment vehicles, by aiming for robust returns. Simultaneously, it supports its portfolio companies by providing essential growth capital, fostering innovation, and enhancing market presence. The fund operates with a long-term vision to contribute to CICC Capital’s overarching goal of becoming a leading, globally influential private equity management platform that drives technological leadership and sustainable economic growth within China.
Zhongjin Qichen Industry Equity Investment Fund has 1 tracked investment across 1 company. The latest tracked deal is $99.0M Series B in Berry Oncology in August 2021.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Aug 1, 2021 | Berry Oncology | $99.0M Series B | China Merchants Capital | Qiming Venture Partners, Fujian Venture Investment Management, Legend Capital |